These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 16846059)

  • 21. [Value of [18F]-FDG-PET/CT as a predictor of cancer in solitary pulmonary nodule].
    Martins Rde C; Almeida SA; Siciliano AA; Landesmann MC; Silva FB; Franco CA; Fonseca LM
    J Bras Pneumol; 2008 Jul; 34(7):473-80. PubMed ID: 18695792
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Is there a role for fluorine 18 fluorodeoxyglucose-positron emission tomography and positron emission tomography/computed tomography in evaluating patients with mycobacteriosis? A systematic review.
    Treglia G; Taralli S; Calcagni ML; Maggi F; Giordano A; Bonomo L
    J Comput Assist Tomogr; 2011; 35(3):387-93. PubMed ID: 21586936
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Growing pulmonary nodule with increased 18-fluorodeoxyglucose uptake in a former smoker.
    Tanaka R; Emerson LL; Karwande SV; Schreiber G
    Chest; 2005 May; 127(5):1848-51. PubMed ID: 15888868
    [No Abstract]   [Full Text] [Related]  

  • 24. The role of ¹⁸F-FDG PET or ¹⁸F-FDG-PET/CT in the evaluation of solitary pulmonary nodules.
    Li W; Pang H; Liu Q; Zhou J
    Eur J Radiol; 2015 Oct; 84(10):2032-7. PubMed ID: 26094866
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [A case of non-tuberculosis mycobacterium and lung cancer showing solitary nodular shadow].
    Kaira K
    Nihon Kokyuki Gakkai Zasshi; 2009 Oct; 47(10):969-70. PubMed ID: 19882925
    [No Abstract]   [Full Text] [Related]  

  • 26. Dual-Time-Point FDG PET/CT to Distinguish Coccidioidal Pulmonary Nodules from Those Due to Malignancy.
    Pasha AK; Walsh TK; Ampel NM
    Lung; 2015 Oct; 193(5):863-4. PubMed ID: 26202257
    [No Abstract]   [Full Text] [Related]  

  • 27. Hypermetabolism on F-18 FDG PET of multiple pulmonary nodules resulting from bronchiolitis obliterans organizing pneumonia.
    Shin L; Katz DS; Yung E
    Clin Nucl Med; 2004 Oct; 29(10):654-6. PubMed ID: 15365446
    [No Abstract]   [Full Text] [Related]  

  • 28. The utility of fluorodeoxyglucose positron emission tomography in the evaluation of carcinoid tumors presenting as pulmonary nodules.
    Daniels CE; Lowe VJ; Aubry MC; Allen MS; Jett JR
    Chest; 2007 Jan; 131(1):255-60. PubMed ID: 17218584
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pulmonary tumor embolus with high (18)FDG uptake mimicking lung metastasis from renal-cell cancer.
    Leuzzi G; Melis E; Forcella D; Facciolo F
    Rev Esp Med Nucl Imagen Mol; 2015; 34(5):325-6. PubMed ID: 25619722
    [No Abstract]   [Full Text] [Related]  

  • 30. The maximum standardized uptake values on integrated FDG-PET/CT is useful in differentiating benign from malignant pulmonary nodules.
    Bryant AS; Cerfolio RJ
    Ann Thorac Surg; 2006 Sep; 82(3):1016-20. PubMed ID: 16928527
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Imaging evaluation of the solitary pulmonary nodule: self-assessment module.
    Ko JP; Roberts CC; Berger WG; Chew FS
    AJR Am J Roentgenol; 2007 Mar; 188(3 Suppl):S1-4. PubMed ID: 19645123
    [TBL] [Abstract][Full Text] [Related]  

  • 32. 18-fluorine fluorodeoxyglucose positron emission tomography with computerized tomography versus computerized tomography alone for the management of solitary lung nodules with diameters inferior to 1.5 cm.
    Divisi D; Di Tommaso S; Di Leonardo G; Brianzoni E; De Vico A; Crisci R
    Thorac Cardiovasc Surg; 2010 Oct; 58(7):422-6. PubMed ID: 20922626
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Fluorine-18 fluorodeoxyglucose positron emission tomography in the management of solitary pulmonary nodule: a review.
    Divisi D; Barone M; Zaccagna G; Crisci R
    Ann Med; 2017 Nov; 49(7):626-635. PubMed ID: 28590774
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Current diagnostic approach for pulmonary nodules].
    Milleron B; Gounant V; Lavole A; Mayaud C
    Rev Pneumol Clin; 2005 Feb; 61(1 Pt 1):3-5. PubMed ID: 15772573
    [No Abstract]   [Full Text] [Related]  

  • 35. PET evaluation of lung cancer.
    Bunyaviroch T; Coleman RE
    J Nucl Med; 2006 Mar; 47(3):451-69. PubMed ID: 16513615
    [No Abstract]   [Full Text] [Related]  

  • 36. Effect of dietary intake before F-18 FDG positron emission tomographic scanning on the evaluation of a solitary pulmonary nodule.
    Ojha B; Bartley SC; Gundlapalli S; Mountz JM
    Clin Nucl Med; 2001 Nov; 26(11):908-9. PubMed ID: 11595840
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Disseminated nocardia infection mimicking malignancy on FDG PET/CT.
    Erdemir RU; Elri T; Sahin H; Sami Salihoglu Y; Aras M; Cabuk M
    Rev Esp Med Nucl Imagen Mol; 2015; 34(4):268-9. PubMed ID: 25935095
    [No Abstract]   [Full Text] [Related]  

  • 38. Non-tuberculous mycobacterial diseases presenting as solitary pulmonary nodules.
    Lim J; Lyu J; Choi CM; Oh YM; Lee SD; Kim WS; Kim DS; Lee H; Shim TS
    Int J Tuberc Lung Dis; 2010 Dec; 14(12):1635-40. PubMed ID: 21144251
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Alternative imaging strategy of solitary pulmonary nodule by FDG PET/CT: Can be imagined a tailored PET?
    Spadafora M; Evangelista L; Gridelli C; Cuocolo A
    Eur J Radiol; 2017 May; 90():188-191. PubMed ID: 28583632
    [TBL] [Abstract][Full Text] [Related]  

  • 40. False-positive FDG positron emission tomography in pulmonary amyloidosis.
    Ollenberger GP; Knight S; Tauro AJ
    Clin Nucl Med; 2004 Oct; 29(10):657-8. PubMed ID: 15365447
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.